SCHEMBL5309199

SCHEMBL5309199

CCOCCNc1cc(Cl)ccc1[N+](=O)[O-]

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.66
LMNA P02545 2/20 0.66
SMN1; SMN2 Q16637 3/20 0.62
TDP1 Q9NUW8 2/20 0.62
ALPG P10696 1/20 0.62
PKM P14618 1/20 0.61
ALDH1A1 P00352 3/20 0.50
NPSR1 Q6W5P4 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.48
POLB P06746 1/20 0.48
KMT2A Q03164 2/20 0.47
HTR6 P50406 1/20 0.47
KAT2B Q92831 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
RAB9A P51151 2/20 0.44
PTGER4 P35408 1/20 0.44
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15060715 0.85 KAT2B (0.61) MAPTLMNASMN1; SMN2TDP1ALPG
SCHEMBL29719483 0.84 LMNA (0.50) MAPTLMNASMN1; SMN2TDP1ALPG
SCHEMBL18496266 0.84 LMNA (0.50) MAPTLMNASMN1; SMN2TDP1ALPG
SCHEMBL12210037 0.84 LMNA (0.50) MAPTLMNASMN1; SMN2TDP1ALPG
SCHEMBL11048929 0.82 MAPT (0.65) MAPTLMNASMN1; SMN2TDP1ALPG
SCHEMBL10799657 0.82 MAPT (0.69) MAPTLMNASMN1; SMN2TDP1ALPG
SCHEMBL741469 0.81 MAPT (0.70) MAPTLMNASMN1; SMN2TDP1ALPG
SCHEMBL2016758 0.81 MAPT (0.63) MAPTLMNASMN1; SMN2TDP1ALPG
SCHEMBL6595723 0.80 MAPT (0.65) MAPTLMNASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL7767318 0.80 MAPT (0.62) MAPTLMNASMN1; SMN2TDP1ALPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007020521-A1 PYRIDOYRAZINONES AS PDE-5 INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2007-02-22 WO disclosed